BioNxt Solutions (DE:BXT)
XETRA:BXT
Total Valuation
BioNxt Solutions has a market cap or net worth of €35.61M. The enterprise value is €59.17M.
Market Cap€35.61M
Enterprise Value€59.17M
Share Statistics
BioNxt Solutions has 129,959,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding129,959,350
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioNxt Solutions’s return on equity (ROE) is 0.75 and return on invested capital (ROIC) is 172.18%.
Return on Equity (ROE)0.75
Return on Assets (ROA)-11.87
Return on Invested Capital (ROIC)172.18%
Return on Capital Employed (ROCE)1.12
Revenue Per Employee0.00
Profits Per Employee-281.02K
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioNxt Solutions is ―. BioNxt Solutions’s PEG ratio is -0.44.
PE Ratio―
PS Ratio0.00
PB Ratio-8.07
Price to Fair Value-8.07
Price to FCF-14.55
Price to Operating Cash Flow―
PEG Ratio-0.44
Income Statement
In the last 12 months, BioNxt Solutions had revenue of 0.00 and earned -7.03M in profits. Earnings per share was -0.06.
Revenue0.00
Gross Profit-10.90K
Operating Income-6.05M
Pretax Income-7.22M
Net Income-7.03M
EBITDA-6.04M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -5.20M and capital expenditures 4.00, giving a free cash flow of -5.20M billion.
Operating Cash Flow-5.20M
Free Cash Flow-5.20M
Free Cash Flow per Share-0.04
Dividends & Yields
BioNxt Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change-32.07%
50-Day Moving Average0.29
200-Day Moving Average0.42
Relative Strength Index (RSI)37.95
Average Volume (3m)30.55K
Important Dates
BioNxt Solutions upcoming earnings date is Aug 31, 2026, Before Open (Confirmed).
Last Earnings DateMay 29, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
BioNxt Solutions as a current ratio of 0.05, with Debt / Equity ratio of ―
Current Ratio0.05
Quick Ratio0.05
Debt to Market Cap0.08
Net Debt to EBITDA-0.98
Interest Coverage Ratio-4.20
Taxes
In the past 12 months, BioNxt Solutions has paid -197.47K in taxes.
Income Tax-197.47K
Effective Tax Rate0.03
Enterprise Valuation
BioNxt Solutions EV to EBITDA ratio is -13.49, with an EV/FCF ratio of -15.69.
EV to Sales0.00
EV to EBITDA-13.49
EV to Free Cash Flow-15.69
EV to Operating Cash Flow-15.69
Balance Sheet
BioNxt Solutions has €55.26K in cash and marketable securities with €6.30M in debt, giving a net cash position of -€5.89M billion.
Cash & Marketable Securities€55.26K
Total Debt€6.30M
Net Cash-€5.89M
Net Cash Per Share-€0.05
Tangible Book Value Per Share-€0.08
Margins
Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin―
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioNxt Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-64.62%
EPS Growth Forecast13.93%